|
Showing the most relevant articles for your search:NASDAQ:AVXS | Date | Time | Source | Headline | Symbol | Company | | 05/04/2018 | 5:10PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 05/03/2018 | 4:01PM | GlobeNewswire Inc. | AveXis Reports First Quarter 2018 Financial and Operating Results | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 05/02/2018 | 9:27AM | GlobeNewswire Inc. | AveXis Provides Update on Proposed Acquisition by Novartis AG | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 05/01/2018 | 7:21AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 05/01/2018 | 7:12AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/30/2018 | 5:26PM | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/25/2018 | 8:44AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/25/2018 | 8:00AM | GlobeNewswire Inc. | AveXis Announces First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3 | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/24/2018 | 4:19PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/24/2018 | 4:01PM | GlobeNewswire Inc. | AveXis Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data from Phase 1 Trial of AVXS-10... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/20/2018 | 5:28PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/20/2018 | 11:51AM | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/19/2018 | 8:00AM | GlobeNewswire Inc. | AveXis to Present AVXS-101 Data at the Annual Meeting of the American Academy of Neurology | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/17/2018 | 4:29PM | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/17/2018 | 4:28PM | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/11/2018 | 5:41PM | PR Newswire (US) | WEISSLAW LLP Investigates AveXis Inc. Acquisition | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/10/2018 | 4:49PM | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/10/2018 | 3:02AM | Dow Jones News | Novartis Deal to Help Drug Pipeline -- WSJ | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/10/2018 | 3:02AM | Dow Jones News | What's News: Business & Finance -- WSJ | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 5:32PM | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 5:28PM | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 5:26PM | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 5:18PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 12:59PM | Dow Jones News | Gene-Therapy Stocks Get Boost as Analysts Speculate Novartis' Next Target -- Market Mover | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 12:00PM | Dow Jones News | Novartis Buying AveXis for $8.7 Billion -- Deal Digest | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 5:10AM | Dow Jones News | Novartis Bets $8.7 Billion on Gene-Therapy Company -- Update | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 3:43AM | Dow Jones News | Novartis Bets $8.7 Billion on Gene Therapy Company | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 3:00AM | Dow Jones News | Novartis to Buy AveXis for $8.7 Billion -- Update | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 1:42AM | Dow Jones News | Novartis to Buy AveXis for $8.7 Billion | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 04/09/2018 | 12:45AM | GlobeNewswire Inc. | AveXis Enters Agreement to be Acquired by Novartis AG for $8.7 billion | NASDAQ:AVXS | Avexis, Inc. (delisted) |
|
Showing the most relevant articles for your search:NASDAQ:AVXS |
|